#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	12180	16S	1529	1529	99.93	16S.l15.c4.ctg.1	2146	560.0	0	.	n	.	0	C1450T	SNP	1450	1450	C	1688	1688	T	688	T,C,G	630,6,1	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	12180	16S	1529	1529	99.93	16S.l15.c4.ctg.1	2146	560.0	1	SNP	n	C1184T	0	.	.	1184	1184	C	1422	1422	C	656	C	638	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	22174	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3573	614.6	0	.	n	.	0	G1337A	SNP	1337	1337	G	1667	1667	A	704	A,G	678,4	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	22174	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3573	614.6	0	.	n	.	0	T1971C	SNP	1971	1971	T	2301	2301	C	635	C	603	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	22174	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3573	614.6	1	SNP	n	A2045G	0	.	.	2045	2045	A	2375	2375	A	651	A	627	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	22174	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3573	614.6	1	SNP	n	C2597T	0	.	.	2597	2597	C	2927	2927	C	672	C,G	652,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_Y_01480c	folP.WHO_Y_01480c	1	1	27	1574	folP	855	855	100.0	folP.l6.c30.ctg.1	1606	96.9	1	SNP	p	R229S	1	.	.	685	687	AGC	1013	1015	AGC	154;154;154	A;G;C	146;145;146	folP.WHO_Y_01480c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4304	gyrA	2751	2751	99.96	gyrA.l15.c4.ctg.1	3387	125.5	1	SNP	p	S91F	1	.	.	271	273	TTC	518	520	TTC	153;153;153	T;T;C	147;146;146	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4304	gyrA	2751	2751	99.96	gyrA.l15.c4.ctg.1	3387	125.5	1	SNP	p	G95N	0	.	.	283	285	GGC	530	532	GGC	153;157;154	G;G,C;C	147;146,1;145	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4304	gyrA	2751	2751	99.96	gyrA.l15.c4.ctg.1	3387	125.5	1	SNP	p	D95G	1	.	.	283	285	GGC	530	532	GGC	153;157;154	G;G,C;C	147;146,1;145	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_Y_01506	mtrR.WHO_Y_01506	1	1	27	1388	mtrR	633	633	100.0	mtrR.l15.c17.ctg.1	1303	105.9	1	SNP	p	G45D	0	.	.	133	135	GGC	509	511	GGC	165;165;165	G;G;C	159;159;157	mtrR.WHO_Y_01506:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	740	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c4.ctg.1	934	78.2	0	.	n	.	0	A197.	DEL	197	197	A	521	521	A	172	A	167	.	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	539	3870	parC	2304	2304	99.87	parC.l15.c4.ctg.1	2858	133.4	0	.	p	.	0	I384V	NONSYN	1150	1152	ATC	1433	1435	GTC	174;173;172	G,A;T;C	165,1;162;167	.	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	539	3870	parC	2304	2304	99.87	parC.l15.c4.ctg.1	2858	133.4	1	SNP	p	D86N	0	.	.	256	258	GAC	539	541	GAC	135;135;138	G;A;C	133;132;136	parC.WHO_V_00204c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	539	3870	parC	2304	2304	99.87	parC.l15.c4.ctg.1	2858	133.4	1	SNP	p	R87W	0	.	.	259	261	CGT	542	544	CGT	140;138;138	C;G;T,C	138;136;134,1	parC.WHO_V_00204c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	539	3870	parC	2304	2304	99.87	parC.l15.c4.ctg.1	2858	133.4	1	SNP	p	R87I	0	.	.	259	261	CGT	542	544	CGT	140;138;138	C;G;T,C	138;136;134,1	parC.WHO_V_00204c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	539	3870	parC	2304	2304	99.87	parC.l15.c4.ctg.1	2858	133.4	1	SNP	p	S87R	1	.	.	259	261	CGT	542	544	CGT	140;138;138	C;G;T,C	138;136;134,1	parC.WHO_V_00204c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	539	3870	parC	2304	2304	99.87	parC.l15.c4.ctg.1	2858	133.4	1	SNP	p	S88P	0	.	.	262	264	TCC	545	547	TCC	137;135;134	T,C;C;C	135,1;133;131	parC.WHO_V_00204c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	539	3320	parE	1986	1986	99.95	parE.l15.c4.ctg.1	2704	121.8	0	.	p	.	0	R340C	NONSYN	1018	1020	CGC	1368	1370	TGC	161;162;157	T;G;C,A	150;158;152,1	.	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	539	3320	parE	1986	1986	99.95	parE.l15.c4.ctg.1	2704	121.8	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1578	1580	GGC	175;175;173	G;G;C	167;168;165	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.12.001	penA.12.001	1	1	27	3254	penA	1749	1749	100.0	penA.l6.c17.ctg.1	2292	139.3	1	SNP	p	A311V	0	.	.	931	933	GCA	1215	1217	GCA	195;197;195	G;C;A	179;183;186	penA.12.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	3254	penA	1749	1749	100.0	penA.l6.c17.ctg.1	2292	139.3	1	SNP	p	I312M	0	.	.	934	936	ATC	1218	1220	ATC	198;196;195	A,C;T;C	186,1;186;185	penA.12.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	3254	penA	1749	1749	100.0	penA.l6.c17.ctg.1	2292	139.3	1	SNP	p	V316P	0	.	.	946	948	GTG	1230	1232	GTG	188;186;187	G;T;G	180;174;178	penA.12.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	3254	penA	1749	1749	100.0	penA.l6.c17.ctg.1	2292	139.3	1	SNP	p	V316T	0	.	.	946	948	GTG	1230	1232	GTG	188;186;187	G;T;G	180;174;178	penA.12.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	3254	penA	1749	1749	100.0	penA.l6.c17.ctg.1	2292	139.3	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1734	1736	ACC	161;160;157	A;C;C	148;150;148	penA.12.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	3254	penA	1749	1749	100.0	penA.l6.c17.ctg.1	2292	139.3	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1788	1790	GCG	128;127;126	G;C;G	123;116;122	penA.12.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	3254	penA	1749	1749	100.0	penA.l6.c17.ctg.1	2292	139.3	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1788	1790	GCG	128;127;126	G;C;G	123;116;122	penA.12.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	3254	penA	1749	1749	100.0	penA.l6.c17.ctg.1	2292	139.3	1	SNP	p	G543S	0	.	.	1627	1629	GGC	1911	1913	GGC	145;142;142	G;G;C,T	138;134;133,1	penA.12.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	3254	penA	1749	1749	100.0	penA.l6.c17.ctg.1	2292	139.3	1	SNP	p	G546S	0	.	.	1636	1638	GGC	1920	1922	GGC	141;137;136	G,A;G;C	128,1;124;124	penA.12.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	3254	penA	1749	1749	100.0	penA.l6.c17.ctg.1	2292	139.3	1	SNP	p	P552S	1	.	.	1654	1656	TCG	1938	1940	TCG	117;116;114	T,G,C;CG,CGG;G	77,16,1;91,1;99	penA.12.001:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	4760	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3069	153.1	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1562	1564	CCG	170;171;168	C;C;G,T	161;163;158,1	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	1972	porA	1146	1146	99.56	porA.l15.c4.ctg.1	1880	103.5	0	.	p	.	0	M83fs	FSHIFT	247	247	A	536	536	C	137	C	131	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2364	porB1b	1047	1047	99.14	porB1b.l15.c17.ctg.1	1382	168.2	0	.	p	.	0	N38E	NONSYN	112	114	AAT	312	314	GAA	193;195;194	G;A;A	186;190;189	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2364	porB1b	1047	1047	99.14	porB1b.l15.c17.ctg.1	1382	168.2	0	.	p	.	0	N134D	NONSYN	400	402	AAT	600	602	GAT	195;195;196	G,A;A;T	190,1;188;192	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2364	porB1b	1047	1047	99.14	porB1b.l15.c17.ctg.1	1382	168.2	0	.	p	.	0	P175S	NONSYN	523	525	CCA	723	725	TCA	218;219;218	T;C;A,G	211;210;211,1	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2364	porB1b	1047	1047	99.14	porB1b.l15.c17.ctg.1	1382	168.2	0	.	p	.	0	A218V	NONSYN	652	654	GCC	852	854	GTC	211;203;205	G;T;C	201;194;201	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2364	porB1b	1047	1047	99.14	porB1b.l15.c17.ctg.1	1382	168.2	0	.	p	.	0	R258H	NONSYN	772	774	CGT	972	974	CAT	185;182;183	C;A;T	180;179;180	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2364	porB1b	1047	1047	99.14	porB1b.l15.c17.ctg.1	1382	168.2	0	.	p	.	0	E328A	NONSYN	982	984	GAA	1182	1184	GCA	149;149;149	G;C;A,C	143;138;141,1	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2364	porB1b	1047	1047	99.14	porB1b.l15.c17.ctg.1	1382	168.2	0	.	p	.	0	D333V	NONSYN	997	999	GAC	1197	1199	GTC	146;147;149	G;T;C	139;139;139	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2364	porB1b	1047	1047	99.14	porB1b.l15.c17.ctg.1	1382	168.2	1	SNP	p	G120K	1	.	.	358	360	AAG	558	560	AAG	177;177;177	A;A;G	170;167;171	porB1b.WHO_V_02265c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2364	porB1b	1047	1047	99.14	porB1b.l15.c17.ctg.1	1382	168.2	1	SNP	p	A121D	1	.	.	361	363	GAC	561	563	GAC	178;173;175	G,A;A;C	169,1;163;168	porB1b.WHO_V_02265c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2364	porB1b	1047	1047	99.14	porB1b.l15.c17.ctg.1	1382	168.2	1	SNP	p	D121N	0	.	.	361	363	GAC	561	563	GAC	178;173;175	G,A;A;C	169,1;163;168	porB1b.WHO_V_02265c:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	8498	rpoB	4179	4179	100.0	rpoB.l15.c4.ctg.1	4904	171.4	1	SNP	p	H553N	1	.	.	1657	1659	AAT	2102	2104	AAT	194;191;190	A;A;T	190;186;183	rpoB.WHO_M_02157:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1052	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1089	95.4	1	SNP	p	V57M	1	.	.	169	171	ATG	574	576	ATG	210;209;203	A;T;G	205;204;200	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
